Thank you for sharing!

Your article was successfully shared with the contacts you provided.
A Merck & Co. doctor on Tuesday told a jury hearing a lawsuit by a Vioxx user that the drugmaker extensively studied the pain reliever’s safety — including its heart safety — both before and after the drug won federal approval in 1999.

Dr. Alise Reicin, vice president of clinical research at Merck Research Labs, told the jury that Merck did multiple studies of Vioxx’s possible risks, and determined the medicine caused no more cardiovascular risk than dummy pills or other painkillers.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.